HCA Healthcare, Inc. HCA
Set alert
467.73 USD -5.46 -1.15%
At close
466.50 -1.23 -0.26%
Pre-market · Nov 3, 6:05 AM ET
460.93 Day range 476.70
353.99 52-week range 556.52
- YTD
- +0.19%
- 1 year
- +1.34%
- Open
- 475.34
- Prev close
- 473.19
- Mkt cap
- 97.71B
- Vol
- 1.39M
- Avg vol
- 1.32M
- EPS
- 30.15
- P/E
- 15.51
- Div yield
- 0.65%
More statistics
- Low
- 460.93
- High
- 476.70
- Forward P/E
- 14.95
- Beta
- 1.10
- Short ratio
- 3.70
- Inst. own
- 81.53%
- Dividend
- 3.12
- Ex-div date
- Dec 14, 2026
- Earnings
- Jan 26, 2027
- 50-d avg
- 437.41
- 200-d avg
- 444.39
- 1y target
- 470.38
5Y chart
Events in this range
- Dec 13, 2021Dividend: 0.48
- Mar 16, 2022Dividend: 0.56
- Jun 15, 2022Dividend: 0.56
- Sep 15, 2022Dividend: 0.56
- Dec 13, 2022Dividend: 0.56
- Dec 28, 2022Dividend: 0.56
- Mar 16, 2023Dividend: 0.6
- Jun 15, 2023Dividend: 0.6
- Sep 14, 2023Dividend: 0.6
- Dec 13, 2023Dividend: 0.6
- Mar 14, 2024Dividend: 0.66
- Jun 14, 2024Dividend: 0.66
- Sep 16, 2024Dividend: 0.66
- Dec 13, 2024Dividend: 0.66
- Mar 17, 2025Dividend: 0.72
- Jun 16, 2025Dividend: 0.72
- Sep 16, 2025Dividend: 0.72
- Oct 24, 2025Earnings: 6.96; estimate 5.79; surprise 20.21%
- Dec 15, 2025Dividend: 0.72
- Jan 27, 2026Earnings: 8.01; estimate 7.46; surprise 7.37%
- Mar 17, 2026Dividend: 0.78
- Apr 24, 2026Earnings: 7.15; estimate 7.12; surprise 0.42%
- Jun 16, 2026Dividend: 0.78
- Jul 24, 2026Earnings: 7.59; estimate 7.56; surprise 0.4%
- Sep 16, 2026Dividend: 0.78
- Oct 27, 2026Earnings: 7.22; estimate 6.65; surprise 8.57%
- Oct 28, 2026Rating: Baird · Neutral → Neutral
- Oct 28, 2026Rating: Keybanc · Overweight → Overweight
- Oct 28, 2026Rating: TD Cowen · Buy → Buy
- Oct 29, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
- Nov 2, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (77)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| RSI: Oversold | May 25, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| RSI: Overbought | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
Newest 20 of 77.
Analyst view
Consensus: buy
Buy
Price target (mean) 470.38 +0.6% upside
Now 467.73
- Target (low)
- 380.00
- Target (mean)
- 470.38
- Target (high)
- 550.00
Ratings (0m) 26 15 buy · 9 hold · 2 sell
- Strong buy1
- Buy14
- Hold9
- Sell1
- Strong sell1
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 8.19 | 7.88 – 8.51 | 8.01 | +2.3% | 20.02B | +2.6% | 17 |
| Next quarter | 7.55 | 6.93 – 7.96 | 7.15 | +5.6% | 19.89B | +4.1% | 12 |
| Current year | 30.15 | 29.85 – 30.43 | 28.21 | +6.9% | 79.15B | +4.7% | 17 |
| Next year | 31.21 | 29.83 – 32.50 | 30.15 | +3.5% | 81.57B | +3.1% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 29, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 28, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 28, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Oct 28, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 28, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Oct 12, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 23, 2026 | BMO Capital | Initiated | — | Outperform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 8, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 20, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 28, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 27, 2026 | UBS | Maintained | Buy | Buy |
| Jul 27, 2026 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jul 27, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 27, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 27, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 16, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 15, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 14, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jul 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |